Prof. Dr. Sabina Gerber
Prof. Dr. Sabina Gerber
ZHAW
School of Life Sciences and Facility Management
Fachstelle Biochemie und Bioanalytik
Einsiedlerstrasse 31
8820 WĂ€denswil
Work at ZHAW
Position
Network
ORCID digital identifier
Projects
- PERISINK â Control of the Peripheral sink and thus serum half-life of biologics via harnessing glycan-specific internalisation / Deputy project leader / ongoing
- Local brain retention for better brain cancer drugs / Project leader / ongoing
- Development of a method for botulism diagnostics / Project leader / ongoing
- Development and bioanalytics of therapeutic mAbs and ADC / Project leader / completed
- Bioanalytics for the development of biopharmaceuticals / Project leader / completed
- Catabolite Identification and Quantification / Project leader / completed
- Endotoxin Quantification / Project leader / completed
- Molecular Mechanism of Host Infection by Bacteriophages / Project leader / completed
- Bioanalytics of multispecific therapeutic antibodies / Project leader / completed
- Enhancement the sensitivity for the pharmacokinetics of a clinical trial / Project leader / completed
- Development of therapeutic mAb and ADCs / Project leader / completed
- Pharmakokinetics for a clinical trial / Project leader / completed
- Molecular mechanism of bacteriophage tail spike proteins in bacterial infection / Project leader / completed
- Mass spectrometric analyses of DARPins / Project leader / completed
- Method development for the quantification of a biopharmaceutical against an auto-immune disease / Project leader / completed
- ELISA Development for the quantification of anti-drug IgG1 antibodies in animal sera / Project leader / completed
- Bioanalytics of vaccine bioconjugate candidates / Project leader / completed
- Method development for the early product quantification / Project leader / completed
- EuroBioTox â European programme for the establishment of validated procedures for the detection and identification of biological toxins / Project leader / completed
Publications
Articles in scientific journal, peer-reviewed
- Josuran, R. et al. (2025) 'N-Glycosylation profile of abrin certified EU reference material', Toxins, 17(3), p. 108. doi: 10.3390/toxins17030108.
- Josuran, R. et al. (2024) 'Glycan profile and sequence variants of certified ricin reference material and other ricin samples yield unique molecular signature features', Toxins, 16(6), p. 243. doi: 10.3390/toxins16060243.
Oral conference contributions and abstracts
- Modenbach, J. M. et al. (2024) 'Design and production of full-length, biologically inactive botulinum neurotoxin serotypes to serve as natively folded antigens for antitoxin generation', in Toxicon. Elsevier. doi: 10.1016/j.toxicon.2024.107459.
- Zeleny, R. et al. (2023) 'First certified reference materials (CRMs) to improve the reliability of biological toxins detection, identification and quantification', in Toxicology Letters. Elsevier, p. S232. doi: 10.1016/s0378-4274(23)00798-1.
Publications before appointment at the ZHAW
- Perez C, Gerber S, Boilevin J, Bucher M, Darbre T, Aebi M, Reymond JL, Locher KP. âStructure and mechanism of a lipid-linked-oligosaccharide flippaseâ Nature 2015;524(7566):433-8.
- Chen F, Gerber S, Korkhov VM, Mireku S, Bucher M, Locher KP, Zenobi R. âOn the Efficiency of NHS Ester Cross-Linkers for Stabilizing Integral Membrane Protein Complexesâ J Am Soc Mass Spectrom 2015;26(3):493-8.
- Park S, Gerber S, Lee JC. âAntibodies to Staphylococcus aureus Serotype 8 Capsular Polysaccharide React with and Protect against Serotype 5 and 8 Isolatesâ Infect Immun 2014;82(12):5049-55.
- Lizak C*, Gerber S*, Zinne D, Michaud G, Schubert M, Chen F, Bucher M, Darbre T, Zenobi R, Reymond JL, Locher KP âA catalytically essential motif in external loop 5 of the bacterial oligosaccharyltransferase PglBâ J Biol Chem 2014;289(2):735-46. *equal contribution
- Lizak C*, Gerber S*, Michaud G, Schubert M, Fan YY, Bucher M, Darbre T, Aebi M, Reymond JL, Locher KP âUnexpected reactivity and mechanism of carboxamide activation in bacterial N-linked protein glycosylationâ, Nat Commun 2013;4:2627. *equal contribution
- Chen F, Gerber S, Heuser K, Korkhov VM, Lizak C, Mireku S, Locher KP, Zenobi R âHigh-mass matrix-assisted laser desorption ionization-mass spectrometry of integral membrane proteins and their complexesâ, Anal Chem 2013, 85(7):3483-8.
- Gerber S*, Lizak C*, Michaud G, Bucher M, Darbre T, Aebi M, Reymond JL, Locher KP. âMechanism of bacterial oligosaccharyltransferase: in vitro quantification of sequon binding and catalysisâ, J Biol Chem 2013 288(13):8849-61. *equal contribution
- Lizak C, Gerber S, Numao S, Aebi M, Locher KP. âX-ray structure of a bacterial oligosaccharyltransferaseâ, Nature, 2011, 474 (7351), 350-355.
- Gerber S*, Comellas-Bigler M*, Goetz BA, Locher KP. âStructural basis of trans-inhibition in a molybdate/tungstate ABC transporterâ Science, 2008, 321 (5886), 246-250. *equal contribution
- Mayer M, Downing PT, Gerber S, Madrid PB, Pinto IG, Guy RK, James TL. âSynthesis and testing of a focused phenothiazine library for binding to HIV-1 TAR RNAâ Chem Biol, 2006, 13(9), 993-1000.
Other publications
- Patent application: METHODS FOR PROTEIN PURIFICATION - WO 20/260436
- Patent application: IMMUNOGENIC COMPOSITION - WO 19/121924 Granted in the US, US11286283
- Patent application: IMMUNOGENIC COMPOSITION - WO 19/121926 Granted in the US, US11819544
Patents and patent applications
Gerber, S. (2025) 'Method of endotoxin detection'. Available at: https://worldwide.espacenet.com/patent/search?q=pn%3DWO2025196246A2.